Your browser doesn't support javascript.
loading
Clinical recognition and management of patients exposed to biological warfare agents.
Franz, D R; Jahrling, P B; McClain, D J; Hoover, D L; Byrne, W R; Pavlin, J A; Christopher, G W; Cieslak, T J; Friedlander, A M; Eitzen, E M.
Affiliation
  • Franz DR; Southern Research Institute, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Clin Lab Med ; 21(3): 435-73, 2001 Sep.
Article in En | MEDLINE | ID: mdl-11572137
ABSTRACT
Concern regarding the use of biological agents (bacteria, viruses, or toxins) as tools of warfare or terrorism has led to measures to deter their use or, failing that, to deal with the consequences. Unlike chemical agents, which typically lead to severe disease syndromes within minutes at the site of exposure, diseases resulting from biological agents have incubation periods of days. Rather than a paramedic, it will likely be a physician who is first faced with evidence of the results of a biological attack. Provided here is an updated primer on 11 classic BW and potential terrorist agents to increase the likelihood of their being considered in a differential diagnosis. Although the resultant diseases are rarely seen in many countries today, accepted diagnostic and epidemiologic principles apply; if the cause is identified quickly, appropriate therapy can be initiated and the impact of a terrorist attack greatly reduced.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Biological Warfare / Communicable Diseases Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Lab Med Year: 2001 Document type: Article Affiliation country: Estados Unidos
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Biological Warfare / Communicable Diseases Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Lab Med Year: 2001 Document type: Article Affiliation country: Estados Unidos